ReP USP - Resultado da busca

Artigo de periodico
ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial (2011)
Titan, S. M.; Vieira Jr., J. M.; Dominguez, W. V.; Barros, R. T.; Zatz, R.
Source: Clinical Nephrology. Unidade: FM
Subjects: NEFROPATIAS (TERAPIA), MÉTODO DUPLO-CEGO, SISTEMA RENINA-ANGIOTENSINA, INSUFICIÊNCIA RENAL CRÔNICA, FATORES SOCIOECONÔMICOS, PROTEINÚRIA (TERAPIA), DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TITAN, S. M. et al. ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial. Clinical Nephrology, v. 76, n. 4, p. 273-283, 2011Tradução . . Disponível em: https://doi.org/10.5414/cn107013. Acesso em: 09 ago. 2024.
APA
Titan, S. M., Vieira Jr., J. M., Dominguez, W. V., Barros, R. T., & Zatz, R. (2011). ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial. Clinical Nephrology, 76( 4), 273-283. doi:10.5414/cn107013
NLM
Titan SM, Vieira Jr. JM, Dominguez WV, Barros RT, Zatz R. ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial [Internet]. Clinical Nephrology. 2011 ; 76( 4): 273-283.[citado 2024 ago. 09 ] Available from: https://doi.org/10.5414/cn107013
Vancouver
Titan SM, Vieira Jr. JM, Dominguez WV, Barros RT, Zatz R. ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial [Internet]. Clinical Nephrology. 2011 ; 76( 4): 273-283.[citado 2024 ago. 09 ] Available from: https://doi.org/10.5414/cn107013
Artigo de periodico
Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma (2010)
Otake, Andréia Hanada; Mattar, Ana Lucia; Freitas, Helano Carioca; Machado, Camila Maria Longo; Nonogaki, Suely; Fujihara, Clarice Kazue; Zatz, Roberto; Chammas, Roger
Source: Cancer Chemotherapy and Pharmacology. Unidade: FM
Subjects: ANGIOTENSINAS, MELANOMA, MODELOS ANIMAIS, FATORES DE CRESCIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OTAKE, Andréia Hanada et al. Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma. Cancer Chemotherapy and Pharmacology, v. 66, n. 1, p. 79-87, 2010Tradução . . Disponível em: https://doi.org/10.1007/s00280-009-1136-0. Acesso em: 09 ago. 2024.
APA
Otake, A. H., Mattar, A. L., Freitas, H. C., Machado, C. M. L., Nonogaki, S., Fujihara, C. K., et al. (2010). Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma. Cancer Chemotherapy and Pharmacology, 66( 1), 79-87. doi:10.1007/s00280-009-1136-0
NLM
Otake AH, Mattar AL, Freitas HC, Machado CML, Nonogaki S, Fujihara CK, Zatz R, Chammas R. Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma [Internet]. Cancer Chemotherapy and Pharmacology. 2010 ; 66( 1): 79-87.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1007/s00280-009-1136-0
Vancouver
Otake AH, Mattar AL, Freitas HC, Machado CML, Nonogaki S, Fujihara CK, Zatz R, Chammas R. Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma [Internet]. Cancer Chemotherapy and Pharmacology. 2010 ; 66( 1): 79-87.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1007/s00280-009-1136-0
Artigo de periodico
The Clinical diagnosis of hypertensive nephrosclerosis: how reliable is it? (1999)
Caetano, E. P.; Zatz, Roberto; Praxedes, José Nery
Unidade: FM
Assunto: NEFROLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAETANO, E. P. e ZATZ, Roberto e PRAXEDES, José Nery. The Clinical diagnosis of hypertensive nephrosclerosis: how reliable is it?. v. 14, n. 2, p. 288-290, 1999Tradução . . Disponível em: https://doi.org/10.1093/ndt/14.2.288. Acesso em: 09 ago. 2024.
APA
Caetano, E. P., Zatz, R., & Praxedes, J. N. (1999). The Clinical diagnosis of hypertensive nephrosclerosis: how reliable is it?, 14( 2), 288-290. doi:10.1093/ndt/14.2.288
NLM
Caetano EP, Zatz R, Praxedes JN. The Clinical diagnosis of hypertensive nephrosclerosis: how reliable is it? [Internet]. 1999 ; 14( 2): 288-290.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1093/ndt/14.2.288
Vancouver
Caetano EP, Zatz R, Praxedes JN. The Clinical diagnosis of hypertensive nephrosclerosis: how reliable is it? [Internet]. 1999 ; 14( 2): 288-290.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1093/ndt/14.2.288
Artigo de periodico
Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease (1996)
Moreno Junior, H; Metze, K; Bento, A C; Antunes, E; Zatz, Roberto; De Nucci, Gilberto
Source: Basic Research of Cardiology. Unidades: FM, ICB
Assunto: NEFROLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENO JUNIOR, H et al. Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease. Basic Research of Cardiology, v. 91, p. 248-55, 1996Tradução . . Disponível em: https://doi.org/10.1007/bf00788911. Acesso em: 09 ago. 2024.
APA
Moreno Junior, H., Metze, K., Bento, A. C., Antunes, E., Zatz, R., & De Nucci, G. (1996). Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease. Basic Research of Cardiology, 91, 248-55. doi:10.1007/bf00788911
NLM
Moreno Junior H, Metze K, Bento AC, Antunes E, Zatz R, De Nucci G. Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease [Internet]. Basic Research of Cardiology. 1996 ;91 248-55.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1007/bf00788911
Vancouver
Moreno Junior H, Metze K, Bento AC, Antunes E, Zatz R, De Nucci G. Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease [Internet]. Basic Research of Cardiology. 1996 ;91 248-55.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1007/bf00788911
Artigo de periodico
Enalapril does notprevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis (1995)
Heitor Moreno, J; Nathan, L E P; Costa, Soraia Katia Pereira ; Metze, K; Antunes, E; Zatz, Roberto; De Nucci, Gilberto
Source: European Journal of Pharmacology. Unidade: FM
Assunto: NEFROLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HEITOR MORENO, J et al. Enalapril does notprevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis. European Journal of Pharmacology, v. 287, p. se 1995, 1995Tradução . . Disponível em: https://doi.org/10.1016/0014-2999(95)00625-x. Acesso em: 09 ago. 2024.
APA
Heitor Moreno, J., Nathan, L. E. P., Costa, S. K. P., Metze, K., Antunes, E., Zatz, R., & De Nucci, G. (1995). Enalapril does notprevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis. European Journal of Pharmacology, 287, se 1995. doi:10.1016/0014-2999(95)00625-x
NLM
Heitor Moreno J, Nathan LEP, Costa SKP, Metze K, Antunes E, Zatz R, De Nucci G. Enalapril does notprevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis [Internet]. European Journal of Pharmacology. 1995 ;287 se 1995.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1016/0014-2999(95)00625-x
Vancouver
Heitor Moreno J, Nathan LEP, Costa SKP, Metze K, Antunes E, Zatz R, De Nucci G. Enalapril does notprevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis [Internet]. European Journal of Pharmacology. 1995 ;287 se 1995.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1016/0014-2999(95)00625-x

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em